For applicants with a neurological disease that is likely to cause a hazard to flight safety, what specific evaluation may be included before a fit assessment is considered?

A fit assessment may be considered after full evaluation, which should include a medical flight test that may be conducted in a flight simulation training device.

What is the minimum period off treatment required before an applicant with a history of a single afebrile epileptiform seizure can be considered for a fit assessment?

There must be no recurrence after at least 10 years off treatment.

What does AMC2 MED.B.065 state about the risk of recurrence for a single afebrile epileptiform seizure to be considered for a fit assessment?

The seizure must be considered to have a very low risk of recurrence.

In the case of functional loss associated with stable neurological disease, what may be considered after full evaluation?

A fit assessment may be considered after full evaluation, which should include a medical flight test that may be conducted in a flight simulation training device.

AMC2 MED.B.065 Neurology

Q: Under AMC2 MED.B.065, what are the three conditions that must be met for an applicant with a history of a single afebrile epileptiform seizure to be assessed as fit?

The applicant may be assessed as fit if: (1) there is a history of a single afebrile epileptiform seizure considered to have a very low risk of recurrence; (2) there has been no recurrence after at least 10 years off treatment; and (3) there is no evidence of continuing predisposition to epilepsy.

Q: What are the conditions under which an applicant with a head injury severe enough to cause loss of consciousness or associated with penetrating brain injury may be assessed as fit?

The applicant may be assessed as fit if there has been a full recovery and the risk of epilepsy is sufficiently low. An evaluation by a neurologist may be required depending on the staging of the original injury.

Navigate / EASA

Ask question Discover more Add to collection

AMC2 MED.B.065 Neurology

ED Decision 2019/002/R

(a) Epilepsy

Applicants may be assessed as fit if:

(1) there is a history of a single afebrile epileptiform seizure, considered to have a very low risk of recurrence;

(2) there has been no recurrence after at least 10 years off treatment; and

(3) there is no evidence of continuing predisposition to epilepsy.

(b) Neurological disease

Applicants with any disease of the nervous system which is likely to cause a hazard to flight safety should be assessed as unfit. However, in certain cases, including cases of functional loss associated with stable disease, a fit assessment may be considered after full evaluation which should include a medical flight test which may be conducted in a flight simulation training device.

Applicants with an established diagnosis of migraine or other severe periodic headaches likely to cause a hazard to flight safety should be assessed as unfit. A fit assessment may be considered after full evaluation. The evaluation should take into account at least the following: auras, visual field loss, frequency, severity, and therapy. Appropriate limitation(s) may apply.

(d) Head injury

Applicants with a head injury which was severe enough to cause loss of consciousness or is associated with penetrating brain injury may be assessed as fit if there has been a full recovery and the risk of epilepsy is sufficiently low. An evaluation by a neurologist may be required depending on the staging of the original injury.

(e) Spinal or peripheral nerve injury

Applicants with a history or diagnosis of spinal or peripheral nerve injury or a disorder of the nervous system due to a traumatic injury should be assessed as unfit. A fit assessment may be considered if neurological evaluation is satisfactory and the conditions of AMC2 MED.B.050 are satisfied.

(f) Vascular deficiencies

Applicants with a disorder of the nervous system due to vascular deficiencies including haemorrhagic and ischaemic events should be assessed as unfit. A fit assessment may be considered if neurological evaluation is satisfactory and the provisions of AMC2 MED.B.050 are met. A cardiological evaluation and medical flight test should be undertaken for applicants with residual deficiencies.

Details

Source-Title: AMC2 MED.B.065 Neurology View latest amendments

Erulesid: ERULES-1963177438-11259 Compare versions

Domain: Aircrew

Applicabilitydate: 30 January, 2019

Entryintoforcedate: 29 January, 2019

Regulatorysource: ED Decision 2019/002/R Navigate

Regulatorysubject: Part-MED

Typeofcontent: AMC to IR (Acceptable means of compliance to implementing rule)

Parentir: MED.B.065 Neurology

Origin: EASA

Category: EAR